In-Home Sensor Monitoring of Older Adults With Cancer

The Washington University

Status: Withdrawn

Conditions: Cancer

Treatments: Other: In-home sensor monitoring

Study type: Interventional

Funder types: Other

Identifiers

NCT04306783

202001189

Details and patient eligibility

About

The investigators propose a pilot study of monitoring a sample of 6 older patients receiving active cancer treatment over a period of 6 months with in-home sensor monitors installed and maintained by Foresite Healthcare. The investigators also propose exploring the beliefs and attitudes of those who are not willing to allow in-home sensor monitoring by asking them to complete a brief survey related to in-home sensor monitoring. The investigators hypothesize that patients will find the equipment acceptable and unintrusive, that changes in home-monitored patient parameters will precede clinical events and that patient trajectories will be more fully characterized with the in home sensors.

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Arm A:

• Age ≥ 65
• Receiving systemic cancer therapy, including conventional chemotherapy, novel/targeted agents OR will begin systemic therapy within the next 4 weeks.
• Estimated life expectancy >1 year
• Anticipated to receive ongoing care at Siteman Cancer Center and its satellite sites
• Willing to have sensors installed in 1-2 primary living areas (e.g. living room and bedroom)
• Continuous home internet connection
• Able to understand and willing to sign an IRB-approved written informed consent document

Arm B:

• Age ≥ 65
• Receiving systemic cancer therapy, including conventional chemotherapy, novel/targeted agents OR will begin systemic therapy within the next 4 weeks.
• Estimated life expectancy >1 year
• Anticipated to receive ongoing care at Siteman Cancer Center and its satellite sites
• Able to understand and willing to sign an IRB-approved written informed consent document

Exclusion criteria

Arm A:

• Inability to read and understand English
• Only receiving hormonal agents (e.g. anti-estrogen or anti-androgen)
• Lives in institutional setting where instrumental activities of daily living are completed for patient by paid staff

Arm B:

• Inability to read and understand English
• Only receiving hormonal agents (e.g. anti-estrogen or anti-androgen)
• Lives in institutional setting where instrumental activities of daily living are completed for patient by paid staff

Trial design

Primary purpose: Supportive Care

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups

Arm A: In-Home Sensor Monitoring

Experimental group

Description:

Older adults with cancer undergoing systemic cancer treatment will undergo passive monitoring with motion sensors and bed sensor. Passive infrared (PIR) motion sensors will be installed in their homes to detect presence in a particular room (e.g., bathroom or kitchen) as well as for specific activities. There will also be a bed sensor, which is a pneumatic strip installed under the bed linens, which measures displacement of the resident's upper torso as he or she lies on the bed. Participants will complete a baseline primarily self-administered survey, an abbreviated assessment with each follow up clinic visit (at least once per month) for 6 months of follow up and a final end of study assessment.

Treatment:

Other: In-home sensor monitoring

Arm B: Survey Only

No Intervention group

Description:

Patients that choose to not proceed with in-home sensor monitoring will be asked to complete a brief survey that explores attitudes regarding in-home sensor monitoring